Chemical Diversity (ChemDiv) is a contract research organization headquartered in San Diego, California, with subsidiaries in Russia and Ukraine. It provides integrated discovery and development solutions to pharmaceutical and biotech companies for their research and development programs. ChemDiv has helped clients develop treatments and drugs for central nervous system, oncology, inflammation, metabolic, infectious and other diseases. Services include identification of a biological target (protein production and assay development) to clinical drug candidates (ADME/DMPK, toxicity and safety studies, and efficacy models) to proof of concept drug candidates (Phase I and II) and to the market. ChemDiv started in 1990 as a chemistry provider and has since become a full service contract research organization. Among its partners are Eli Lilly, Novartis, Dendreon, Merck KGaA, Solvay Pharmaceuticals, and Bayer.